Document Detail

Role of positron emission tomography in decisions on treatment strategies for pancreatic cancer.
MedLine Citation:
PMID:  17013719     Owner:  NLM     Status:  MEDLINE    
BACKGROUND/PURPOSE: The purpose of this study was to estimate the usefulness of positron emission tomography (PET) in deciding on strategies for the treatment of pancreatic cancer. The following two parameters were evaluated: the ability of PET to provide an estimation of the progression of pancreatic cancer, and the ability of PET to predict survival and the effect of chemoradiotherapy. METHODS: Forty-two patients underwent PET as part of the procedure for making a diagnosis of pancreatic tumors. The maximum standardized uptake value (SUVmax) levels were compared with clinicopathological factors and analyzed. RESULTS: PET provided a sensitivity of 87%, a specificity of 67%, and an overall accuracy of 85% for the diagnosis of pancreatic malignancy. Tumors with distant metastases showed significantly higher SUV levels than tumors without metastasis. In the patients who received chemoradiotherapy, the overall survival of the group in which SUVmax was less than 7.0 was better than that of the group in which SUVmax was more than 7.0. CONCLUSIONS: We conclude that PET is a useful tool for determining pathological status and distant metastasis in pancreatic cancer, and for predicting the prognosis of patients receiving chemoradiotherapy.
Kosei Maemura; Sonshin Takao; Hiroyuki Shinchi; Hidetoshi Noma; Yukou Mataki; Hiroshi Kurahara; Seishi Jinnouchi; Takashi Aikou
Related Documents :
21822309 - Fra-1 controls motility of bladder cancer cells via transcriptional upregulation of the...
16418249 - Ct and pet in stomach cancer: preoperative staging and monitoring of response to therapy.
24558509 - Acr appropriateness criteria®-anal cancer.
16292879 - Fluorescent nanoparticle probes for cancer imaging.
10202949 - Increased fdg uptake in the wall of the right atrium in people who participated in a ca...
24630909 - Advantages and limitations of navigation-based multicriteria optimization (mco) for loc...
14767219 - A 50-year historical cohort mortality study of workers in a pharmaceutical plant.
22884489 - 25(oh)d3 in patients with ovarian cancer and its correlation with survival.
15751599 - Barriers and facilitators of colon cancer screening among patients at faith-based neigh...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of hepato-biliary-pancreatic surgery     Volume:  13     ISSN:  0944-1166     ISO Abbreviation:  J Hepatobiliary Pancreat Surg     Publication Date:  2006  
Date Detail:
Created Date:  2006-10-02     Completed Date:  2007-03-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9431940     Medline TA:  J Hepatobiliary Pancreat Surg     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  435-41     Citation Subset:  IM    
Department of Surgical Oncology and Digestive Surgery, Field of Oncology, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima, 890-8520, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Combined Modality Therapy
Decision Making
Disease Progression
Middle Aged
Neoplasm Metastasis
Pancreatic Neoplasms / mortality,  radionuclide imaging*,  therapy*
Positron-Emission Tomography*
Sensitivity and Specificity

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Analysis of bile duct injuries (Stewart-Way classification) during laparoscopic cholecystectomy.
Next Document:  Type-2 dominant cytokine gene expression following hepatic surgery.